The driver oncogene of deep penetrating melanoma is GRIN2A (N-methyl-D-aspartate receptor glutamate ionotropic receptor NMDA type subunit 2A), while the nevus-like melanoma is characterized by mutations of the lipid/AKT signaling pathway. Here, GRIN2A is linked to melanoma.